128 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19248893 | METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREBY | KIM, YUNSOO | 1641 | Final Rejection | Jun 25, 2025 |
| 19187394 | SYSTEMS AND METHODS FOR A REGULATORY-COMPLIANT AUTOMATED ASSAY | THOMPSON, CURTIS A | 1798 | Non-Final OA | Apr 23, 2025 |
| 19187429 | SYSTEMS AND METHODS FOR A REGULATORY-COMPLIANT AUTOMATED ASSAY | THOMPSON, CURTIS A | 1798 | Non-Final OA | Apr 23, 2025 |
| 18763490 | METHODS AND COMPOSITIONS FOR MODIFYING A TARGETED LOCUS | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Non-Final OA | Jul 03, 2024 |
| 18680910 | ANTI-NPR1 ANTIBODIES AND USES THEREOF | HOWARD, ZACHARY C | 1674 | Non-Final OA | May 31, 2024 |
| 18584551 | ANTI-ACVR1 ANTIBODIES AND USES THEREOF | DEBERRY, REGINA M | 1647 | Non-Final OA | Feb 22, 2024 |
| 18429887 | Methods of Treating Multiple Myeloma with Bispecific Anti-BCMA x Anti-CD3 Antibodies | KAUFMAN, CLAIRE M | 1674 | Final Rejection | Feb 01, 2024 |
| 18424371 | PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS | JONES, DAMERON LEVEST | 1618 | Final Rejection | Jan 26, 2024 |
| 18420090 | SYSTEMS AND METHODS FOR MOBILE AND STATIC BIOMETRIC MOVEMENT TRACKING | DING, XIAOMAO | 2676 | Non-Final OA | Jan 23, 2024 |
| 18407331 | METHODS FOR REDUCING OR ELIMINATING THE NEED FOR LIPOPROTEIN APHERESIS IN PATIENTS WITH HYPERLIPIDEMIA BY ADMINISTERING ALIROCUMAB | WEN, SHARON X | 1641 | Non-Final OA | Jan 08, 2024 |
| 18540970 | METHODS AND SYSTEMS FOR ASSESSING CHROMATOGRAPHIC COLUMN INTEGRITY | DRODGE, JOSEPH W | 1773 | Non-Final OA | Dec 15, 2023 |
| 18514880 | CELL CULTURE MEDIUM FOR EUKARYOTIC CELLS | KIM, TAEYOON | 1631 | Non-Final OA | Nov 20, 2023 |
| 18389403 | METHODS FOR ASSAYING ENZYME ACTIVITY | MCKNIGHT, CIARA A | 1656 | Non-Final OA | Nov 14, 2023 |
| 18499538 | METHODS, DEVICES, AND SYSTEMS FOR SPATIAL TRANSCRIPTOME SLIDE ALIGNMENT | FITZPATRICK, ATIBA O | 2677 | Non-Final OA | Nov 01, 2023 |
| 18495182 | METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST | MERTZ, PREMA MARIA | 1674 | Non-Final OA | Oct 26, 2023 |
| 18485592 | Treatment Of Ophthalmic Conditions With Son of Sevenless 2 (SOS2) Inhibitors | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Oct 12, 2023 |
| 18482448 | ANTI-PTCRA ANTIBODY-DRUG CONJUGATES AND USES THEREOF | HUYNH, PHUONG N | 1641 | Non-Final OA | Oct 06, 2023 |
| 18244577 | Treatment Of Endometriosis With R-Spondin 3 (RSPO3) Inhibitors | TATGE, LEXUS MARC | 1637 | Non-Final OA | Sep 11, 2023 |
| 18462692 | ANTI-FGFR2 ANTIBODIES AND METHODS OF USE THEREOF | REDDIG, PETER J | 1646 | Non-Final OA | Sep 07, 2023 |
| 18462320 | METHOD OF TREATING AN ALLERGY WITH ALLERGEN-SPECIFIC MONOCLONAL ANTIBODIES | TAYLOR, LIA ELAN | 1641 | Non-Final OA | Sep 06, 2023 |
| 18237210 | SITE-SPECIFIC QUANTITATION OF DRUG CONJUGATIONS | PUTTLITZ, KARL J | 1646 | Non-Final OA | Aug 23, 2023 |
| 18237239 | COMMON LIGHT CHAIN MOUSE | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Aug 23, 2023 |
| 18453207 | ANTI-HEMAGGLUTININ ANTIBODIES AND METHODS OF USE THEREOF | REDDIG, PETER J | 1646 | Non-Final OA | Aug 21, 2023 |
| 18355108 | Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof | SCHWECHTER, BRANDON ROSS | 1674 | Non-Final OA | Jul 19, 2023 |
| 18221934 | ISOELECTRIC FOCUSING-BASED ENRICHMENT OF CHARGE VARIANT SPECIES | FRITCHMAN, REBECCA M | 1758 | Non-Final OA | Jul 14, 2023 |
| 18349012 | METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R ANTAGONIST | HECK, BRYAN WILLIAM | 1643 | Non-Final OA | Jul 07, 2023 |
| 18218532 | COMPOSITIONS AND METHODS FOR REDUCING BIOBURDEN IN CHROMATOGRAPHY | CHORBAJI, MONZER R | 1799 | Non-Final OA | Jul 05, 2023 |
| 18345975 | BOTULINUM NEUROTOXIN-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING | LIEB, JEANETTE M | 1654 | Final Rejection | Jun 30, 2023 |
| 18340917 | NON-HUMAN ANIMALS HAVING A HUMANIZED CLEC9A GENE | CANDELARIA, JULIANA IRENE | 1634 | Non-Final OA | Jun 26, 2023 |
| 18336148 | SYSTEMS AND METHODS FOR DRUG DELIVERY TO OCULAR TISSUE | MEDWAY, SCOTT J | 3783 | Non-Final OA | Jun 16, 2023 |
| 18336644 | FAST PROTEIN SEQUENCING | CHEU, CHANGHWA J | 1678 | Non-Final OA | Jun 16, 2023 |
| 18257793 | NUCLEIC ACIDS ENCODING ANCHOR MODIFIED ANTIBODIES AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 1641 | Non-Final OA | Jun 15, 2023 |
| 18208394 | METHODS FOR CHARACTERIZING HOST-CELL PROTEINS | FAN, LYNN Y | 1759 | Non-Final OA | Jun 12, 2023 |
| 18204801 | NATIVE MICROFLUIDIC CE-MS ANALYSIS OF ANTIBODY CHARGE HETEROGENEITY | XU, XIAOYUN | 1797 | Non-Final OA | Jun 01, 2023 |
| 18319245 | MULTISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND CD38 AND 4-1BB, AND USES THEREOF | SWARTWOUT, BRIANNA KENDALL | 1644 | Non-Final OA | May 17, 2023 |
| 18317241 | ANTI-LAG3 ANTIBODIES AND USES THEREOF | OUSPENSKI, ILIA I | 1644 | Non-Final OA | May 15, 2023 |
| 18142196 | Anti-Interleukin-4 Receptor (IL-4R) Antibody Formulations | REN, HONG | 1647 | Non-Final OA | May 02, 2023 |
| 18307309 | METHODS FOR SELECTING PATIENTS FOR TREATMENT WITH AN NGF ANTAGONIST | O'BRIEN, LEA S | 1646 | Non-Final OA | Apr 26, 2023 |
| 18306737 | Transcriptome Analysis For Treating Inflammation | SMITH, EMILIE ALINE | 1686 | Non-Final OA | Apr 25, 2023 |
| 18247226 | COMBINATION OF ANTIBODIES FOR TREATING CANCER WITH REDUCED CYTOKINE RELEASE SYNDROME | STONEBRAKER, ALYSSA RAE | 1642 | Non-Final OA | Mar 29, 2023 |
| 18187564 | PRECISION DOSE DELIVERY DEVICE PLUNGER ROD INSERTION GAUGE AND METHODS THEREFOR | NGUYEN, ANDREW H | 3741 | Non-Final OA | Mar 21, 2023 |
| 18185624 | METHODS AND SYSTEMS FOR ANALYZING POLYPEPTIDE VARIANTS | LIRIANO, MELISSA LIZETTE | 1677 | Non-Final OA | Mar 17, 2023 |
| 18182323 | ANTI-GLP1R ANTIBODY-TETHERED DRUG CONJUGATES COMPRISING GLP1 PEPTIDOMIMETICS AND USES THEREOF | ALLEN, MARIANNE P | 1647 | Non-Final OA | Mar 11, 2023 |
| 17969033 | METHODS FOR TREATING PRURIGO NODULARIS BY ADMINISTERING AN IL-4R ANTAGONIST | NATARAJAN, MEERA | 1643 | Final Rejection | Mar 02, 2023 |
| 18115285 | BIOREACTOR FOR ANTIBODY PRODUCTION | CANDELARIA, JULIANA IRENE | 1634 | Non-Final OA | Feb 28, 2023 |
| 18171045 | METHODS AND SYSTEMS FOR SEQUENCE GENERATION AND PREDICTION | PARISI, JESSICA DANIELLE | 1684 | Non-Final OA | Feb 17, 2023 |
| 18169345 | ANTI-IL2 RECEPTOR GAMMA ANTIGEN-BINDING PROTEINS | LANDSMAN, ROBERT S | 1647 | Non-Final OA | Feb 15, 2023 |
| 18110130 | SEQUENCE VARIANT ANALYSIS USING HEAVY PEPTIDES | ALABI, OYELEYE A | 1797 | Non-Final OA | Feb 15, 2023 |
| 18167517 | COMPOSITIONS AND METHODS FOR SCREENING 4R TAU TARGETING AGENTS | JOHNSON, ALLISON MARIE | 1638 | Non-Final OA | Feb 10, 2023 |
| 18164171 | MEDICAL DEVICE PACKAGING AND RELATED METHODS | REYNOLDS, STEVEN ALAN | 3735 | Non-Final OA | Feb 03, 2023 |
| 18101310 | Dosing Strategy that Mitigates Cytokine Release Syndrome for Therapeutic Antibodies | XIE, XIAOZHEN | 1674 | Non-Final OA | Jan 25, 2023 |
| 18157587 | Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors | CASH, KAILEY ELIZABETH | 1683 | Non-Final OA | Jan 20, 2023 |
| 18155324 | DEVICES AND METHODS FOR A VIAL ADAPTER ASSEMBLY | ZIMBOUSKI, ARIANA | 3781 | Non-Final OA | Jan 17, 2023 |
| 18152346 | Triggering Receptor Expressed On Myeloid Cells 2 (TREM2) Variants And Uses Thereof | SALMON, KATHERINE D | 1682 | Non-Final OA | Jan 10, 2023 |
| 18095467 | PROTEIN-DRUG CONJUGATES COMPRISING CAMPTOTHECIN ANALOGS AND METHODS OF USE THEREOF | CANELLA, KAREN A | 1643 | Non-Final OA | Jan 10, 2023 |
| 18094176 | Methods of Treating Recurrent Ovarian Cancer with Bispecific Anti-MUC16 x Anti-CD3 Antibodies Alone or in Combination with Anti-PD-1 Antibodies | DRISCOLL, MAUREEN VARINA | 1644 | Non-Final OA | Jan 06, 2023 |
| 18067982 | Methods Of Identifying And Evaluating Liver Inflammation And Liver Fibrosis In A Subject By Determining A Stratified Score Based On Gene Expression | BICKHAM, DAWN MARIE | 1685 | Non-Final OA | Dec 19, 2022 |
| 18067085 | Treatment Of Lung Conditions With Integrin Subunit Alpha 1 (ITGA1) Inhibitors | PAK, MICHAEL D | 1674 | Non-Final OA | Dec 16, 2022 |
| 18009239 | METHODS FOR MANUFACTURING VIRAL VECTORS | NGUYEN, QUANG | 1631 | Non-Final OA | Dec 08, 2022 |
| 18077139 | Bispecific Anti-PSMA x Anti-CD28 Antibodies and Uses Thereof | ALLEN, MARIANNE P | 1647 | Final Rejection | Dec 07, 2022 |
| 18059719 | Treatment Of Lung Disease Based Upon Stratification Of Polygenic Score Relating To Response To A Therapeutic Agent | GODDARD, LAURA B | 1642 | Final Rejection | Nov 29, 2022 |
| 18059315 | ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF | MCCOLLUM, ANDREA K | 1674 | Non-Final OA | Nov 28, 2022 |
| 18055895 | AUTO-INJECTOR AND RELATED METHODS OF USE | GONZALEZ, LEI NMN | 3783 | Final Rejection | Nov 16, 2022 |
| 18051488 | Association Of T Cell Leukemia/Lymphoma Protein 1A (TCL1A) With Clonal Hematopoiesis Of Indeterminate Potential (CHIP) | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | Oct 31, 2022 |
| 17973638 | SYSTEMS AND METHODS FOR GENERATING LABORATORY WATER AND DISTRIBUTING LABORATORY WATER AT DIFFERENT TEMPERATURES | GURTOWSKI, RICHARD C | 1773 | Final Rejection | Oct 26, 2022 |
| 17920069 | NON-HUMAN ANIMALS HAVING A HUMANIZED CXCL13 GENE | DHAR, MATASHA | 1632 | Final Rejection | Oct 20, 2022 |
| 17918830 | MODIFIED CCR POLYPEPTIDES AND USES THEREOF | CANDELARIA, JULIANA IRENE | 1634 | Non-Final OA | Oct 13, 2022 |
| 18045588 | ANTIBODIES TO HUMAN GDF8 | XIE, XIAOZHEN | 1674 | Final Rejection | Oct 11, 2022 |
| 17936715 | Treatment Of Psychiatric Disorders And Psychiatric Disorder-Associated MRI Phenotypes With Stabilin 1 (STAB1) Inhibitors | ANGELL, JON E | 1637 | Non-Final OA | Sep 29, 2022 |
| 17954999 | ASSAYS TO QUANTITATE DRUG AND TARGET CONCENTRATIONS | EVANS, CHRISTOPHER RYAN | 1677 | Non-Final OA | Sep 28, 2022 |
| 17951801 | AUTO-INJECTOR WITH ANTI-ROLL FEATURES | SCHMIDT, EMILY LOUISE | 3783 | Non-Final OA | Sep 23, 2022 |
| 17934259 | COMPOSITIONS AND METHODS FOR TREATING JUVENILE IDIOPATHIC ARTHRITIS | XIE, XIAOZHEN | 1674 | Non-Final OA | Sep 22, 2022 |
| 17934277 | Methods Of Treating Chronic Kidney Disease (CKD) With Inhibitors Of Protective Loss-Of-Function Genes | KENYON, JOHN S | 1625 | Non-Final OA | Sep 22, 2022 |
| 17948496 | METHODS FOR CHARACTERIZING HOST-CELL PROTEINS | BERKELEY, EMILY R | 1796 | Non-Final OA | Sep 20, 2022 |
| 17945398 | METHOD TO PREVENT SAMPLE PREPARATION-INDUCED DISULFIDE SCRAMBLING IN NON-REDUCED PEPTIDE MAPPING | COOK, LISA V | 1642 | Non-Final OA | Sep 15, 2022 |
| 17943776 | NMASS SPECTROMETRY-BASED STRATEGY FOR CHARACTERIZING HIGH MOLECULAR WEIGHT SPECIES OF A BIOLOGIC | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | Final Rejection | Sep 13, 2022 |
| 17931396 | Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential (CHIP) With Lymphocyte Antigen 75 (LY75), Cluster Of Differentiation 164 (CD164), Or Poly(ADP-Ribose) Polymerase 1 (PARP1) Inhibitors | DARPOLOR, JOSEPHINE KEBBEH | 1642 | Final Rejection | Sep 12, 2022 |
| 17821806 | Treatment Of Inflammatory Diseases With RAS Protein Activator Like 3 (RASAL3) Inhibitors | VYAS, KEYUR ANILKUMAR | 1637 | Final Rejection | Aug 24, 2022 |
| 17821665 | METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | Non-Final OA | Aug 23, 2022 |
| 17887565 | IL27 RECEPTOR AGONISTS AND METHODS OF USE THEREOF | DONOGHUE, BRITTNEY ERIN | 1675 | Final Rejection | Aug 15, 2022 |
| 17885805 | MASS SPECTROMETRY-BASED STRATEGY FOR DETERMINING PRODUCT-RELATED VARIANTS OF A BIOLOGIC | WHITE, ASHLEY TAYLOR | 1653 | Non-Final OA | Aug 11, 2022 |
| 17875295 | Methods and Antibody Compositions for Tumor Treatment | SKELDING, ZACHARY S | 1644 | Non-Final OA | Jul 27, 2022 |
| 17872225 | METHODS FOR TREATING CHRONIC SPONTANEOUS URTICARIA BY ADMINISTERING AN IL-4R ANTAGONIST | PATTERSON, SARAH COOPER | 1675 | Final Rejection | Jul 25, 2022 |
| 17813100 | COMBINATION OF CHECKPOINT INHIBITORS AND AN ONCOLYTIC VIRUS FOR TREATING CANCER | MOSELEY II, NELSON B | 1642 | Non-Final OA | Jul 18, 2022 |
| 17863303 | MASS SPECTROMETRY-BASED STRATEGY FOR DETERMINING PRODUCT-RELATED VARIANTS OF A BIOLOGIC | WHITE, ASHLEY TAYLOR | 1653 | Final Rejection | Jul 12, 2022 |
| 17862240 | Methods for Viral Particle Characterization Using Two-Dimensional Liquid Chromatography-Mass Spectrometry | ZOU, NIANXIANG | 1671 | Non-Final OA | Jul 11, 2022 |
| 17810820 | Treatment of Varicose Veins With Piezo Type Mechanosensitive Ion Channel Component 1 (PIEZO1) Agonists | MYERS, CARLA J | 1682 | Final Rejection | Jul 05, 2022 |
| 17855053 | Methods Of Treating Decreased Bone Mineral Density With Kringle Containing Transmembrane Protein 1 (KREMEN1) Inhibitors | POLIAKOVA-GEORGAN, EKATERINA | 1637 | Non-Final OA | Jun 30, 2022 |
| 17854283 | Methods Of Treating Asthma With Solute Carrier Family 27 Member 3 (SLC27A3) Inhibitors | KAPUSHOC, STEPHEN THOMAS | 1683 | Final Rejection | Jun 30, 2022 |
| 17854412 | Methods Of Treating A Metabolic Disorder With Mitogen-Activated Protein Kinase Kinase Kinase 15 (MAP3K15) Inhibitors | KAPUSHOC, STEPHEN THOMAS | 1683 | Final Rejection | Jun 30, 2022 |
| 17711800 | Stabilized Formulations Containing Anti-MUC16 x Anti-CD3 Bispecific Antibodies | BERHANE, SELAM | 1675 | Final Rejection | Apr 01, 2022 |
| 17657254 | METHODS AND SYSTEMS FOR STERILIZATION | LEE, AHAM NMN | 1758 | Non-Final OA | Mar 30, 2022 |
| 17687051 | METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | HOWARD, ZACHARY C | 1674 | Non-Final OA | Mar 04, 2022 |
| 17676338 | NON-HUMAN ANIMALS HAVING AN IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION THAT INCLUDES AN ENGINEERED DIVERSITY CLUSTER AND USES THEREOF | WILSON, MICHAEL C | 1638 | Non-Final OA | Feb 21, 2022 |
| 17584642 | Methods Of Improving Health With Apolipoprotein E (APOE) Inhibitors | SUNSHINE, HANNAH LOUISE | 1647 | Non-Final OA | Jan 26, 2022 |
| 17579185 | RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN MICE | WEHBE, ANNE MARIE SABRINA | 1634 | Final Rejection | Jan 19, 2022 |
| 17575450 | HUMANIZED T CELL MEDIATED IMMUNE RESPONSES IN NON-HUMAN ANIMALS | MOLOYE, TITILAYO | 1632 | Non-Final OA | Jan 13, 2022 |
| 17565104 | AUTO-INJECTOR AND RELATED METHODS OF USE | ZAMORY, JUSTIN L | 3783 | Non-Final OA | Dec 29, 2021 |
| 17616295 | NON-HUMAN ANIMALS HAVING A LIMITED LAMBDA LIGHT CHAIN REPERTOIRE EXPRESSED FROM THE KAPPA LOCUS AND USES THEREOF | SINGH, ANOOP KUMAR | 1632 | Final Rejection | Dec 03, 2021 |
| 17615732 | MODIFIED DOSAGE OF SUBCUTANEOUS TOCILIZUMAB FOR RHEUMATOID ARTHRITIS | HECK, BRYAN WILLIAM | 1643 | Final Rejection | Dec 01, 2021 |
| 17612669 | MODIFIED VIRAL PARTICLES AND USES THEREOF | RIGA, MICHAEL ANGELO | 1634 | Final Rejection | Nov 19, 2021 |
| 17611073 | COMBINATION OF PD-1 INHIBITORS AND LAG-3 INHIBITORS FOR ENHANCED EFFICACY IN TREATING CANCER | HECK, BRYAN WILLIAM | 1643 | Non-Final OA | Nov 12, 2021 |
| 17602562 | HUMAN ANTIBODIES THAT BIND RET AND METHODS OF USE THEREOF | O'BRIEN, LEA S | 1646 | Final Rejection | Oct 08, 2021 |
| 17476078 | Use of LEPR Agonists for Pain | CHERNYSHEV, OLGA N | 1675 | Non-Final OA | Sep 15, 2021 |
| 17469308 | METHOD FOR DETECTING HOST CELL PROTEINS IN THERAPEUTIC ANTIBODIES BY COMBINING TRYPSIN DIGESTION, CHROMATOGRAPHY GRADIENTS, AND BOXCAR MASS SPECTROMETRY | SWIFT, CANDICE LEE | 1657 | Non-Final OA | Sep 08, 2021 |
| 17409158 | CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN | BABIC, CHRISTOPHER M | 1633 | Non-Final OA | Aug 23, 2021 |
| 17443702 | Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors | HUDSON, AMY ROSE | 1636 | Final Rejection | Jul 27, 2021 |
| 17356497 | TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES | CANELLA, KAREN A | 1643 | Non-Final OA | Jun 23, 2021 |
| 17415589 | Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A | MELCHIOR, JAMES RYLAND | 1644 | Final Rejection | Jun 17, 2021 |
| 17236998 | METHODS AND SYSTEMS FOR ANALYSIS OF RECEPTOR INTERACTION | SABOUR, GHAZAL | 1686 | Non-Final OA | Apr 21, 2021 |
| 17204636 | METHODS AND SYSTEMS FOR DETERMINING RESPONDERS TO TREATMENT | AUGER, NOAH ANDREW | 1687 | Final Rejection | Mar 17, 2021 |
| 17204253 | NON-HUMAN ANIMALS THAT SELECT FOR LIGHT CHAIN VARIABLE REGIONS THAT BIND ANTIGEN | NGUYEN, NAM P | 1678 | Non-Final OA | Mar 17, 2021 |
| 17183904 | COMPOSITIONS COMPRISING IL6R ANTIBODIES FOR THE TREATMENT OF UVEITIS AND MACULAR EDEMA AND METHODS OF USING SAME | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | Feb 24, 2021 |
| 17268719 | METHOD AND CHROMATOGRAPHY SYSTEM FOR DETERMINING AMOUNT AND PURITY OF A MULTIMERIC PROTEIN | GERMAIN, ADAM ADRIEN | 1777 | Non-Final OA | Feb 16, 2021 |
| 17168708 | MICE THAT MAKE VL BINDING PROTEINS | WILSON, MICHAEL C | 1638 | Final Rejection | Feb 05, 2021 |
| 17143890 | Use of Amino Acids to Enhance Signal in Mass Spectral Analyses | HUANG, MICKEY NMN | 1758 | Final Rejection | Jan 07, 2021 |
| 17113485 | GENETICALLY MODIFIED MICE THAT EXPRESS HUMANIZED IgG1 LACKING A CH1 DOMAIN AND HUMANIZED UNIVERSAL LIGHT CHAIN | WILSON, MICHAEL C | 1638 | Non-Final OA | Dec 07, 2020 |
| 17112198 | METHODS FOR TREATING COPD BY ADMINISTERING AN IL-33 ANTAGONIST | BENAVIDES, JENNIFER ANN | 1675 | Final Rejection | Dec 04, 2020 |
| 17095562 | METHODS AND SYSTEMS FOR IDENTIFYING, CLASSIFYING, AND/OR RANKING GENETIC SEQUENCES | HAYES, JONATHAN EDWARD | 1685 | Final Rejection | Nov 11, 2020 |
| 17091484 | Accurate And Robust Information-Deconvolution From Bulk Tissue Transcriptomes | STRIEGEL, THEODORE CHARLES | 1685 | Final Rejection | Nov 06, 2020 |
| 17078137 | Systems and Methods for Auto-Inoculation in Seed Train and Production Processes | BAILEY, STEVEN WILLIAM | 1687 | Final Rejection | Oct 23, 2020 |
| 17041252 | GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS OF MAKING AND USES THEREOF | WILSON, MICHAEL C | 1638 | Final Rejection | Sep 24, 2020 |
| 16991283 | GENETICALLY MODIFIED MAJOR HISTOCOMPATIBILITY COMPLEX MICE | WILSON, MICHAEL C | 1638 | Final Rejection | Aug 12, 2020 |
| 16817458 | CROSS-LINKED EPITOPES AND METHODS OF USE THEREOF | GROSS, CHRISTOPHER M | 1684 | Final Rejection | Mar 12, 2020 |
| 16625207 | Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells | GROOMS, TIFFANY NICOLE | 1637 | Final Rejection | Dec 20, 2019 |
| 16278611 | GAN-CNN FOR MHC PEPTIDE BINDING PREDICTION | BICKHAM, DAWN MARIE | 1685 | Non-Final OA | Feb 18, 2019 |
| 16042099 | Stabilized Antibody Compositions and Methods of Producing Same | SCHULTZHAUS, JANNA NICOLE | 1685 | Final Rejection | Jul 23, 2018 |
| 15505056 | COMPOSITIONS FOR IMPROVING THE HEALTH RELATED QUALITY OF LIFE OF RHEUMATOID ARTHRITIS PATIENTS | JIANG, DONG | 1674 | Non-Final OA | Feb 17, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial